Walch A - Search Results

1

HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study.

Haffner I, Schierle K, Raimúndez E, Geier B, Maier D, Hasenauer J, Luber B, Walch A, Kolbe K, Riera Knorrenschild J, Kretzschmar A, Rau B, Fischer von Weikersthal L, Ahlborn M, Siegler G, Fuxius S, Decker T, Wittekind C, Lordick F. Haffner I, et al. Among authors: walch a. J Clin Oncol. 2021 May 1;39(13):1468-1478. doi: 10.1200/JCO.20.02761. Epub 2021 Mar 25. J Clin Oncol. 2021. PMID: 33764808 Free PMC article.

2

Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.

Bremm A, Walch A, Fuchs M, Mages J, Duyster J, Keller G, Hermannstädter C, Becker KF, Rauser S, Langer R, von Weyhern CH, Höfler H, Luber B. Bremm A, et al. Among authors: walch a. Cancer Res. 2008 Feb 1;68(3):707-14. doi: 10.1158/0008-5472.CAN-07-1588. Cancer Res. 2008. PMID: 18245470

3

Combined analysis of Rac1, IQGAP1, Tiam1 and E-cadherin expression in gastric cancer.

Walch A, Seidl S, Hermannstädter C, Rauser S, Deplazes J, Langer R, von Weyhern CH, Sarbia M, Busch R, Feith M, Gillen S, Höfler H, Luber B. Walch A, et al. Mod Pathol. 2008 May;21(5):544-52. doi: 10.1038/modpathol.2008.3. Epub 2008 Feb 1. Mod Pathol. 2008. PMID: 18246045 Free article.

4

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients.

Aubele M, Walch AK, Ludyga N, Braselmann H, Atkinson MJ, Luber B, Auer G, Tapio S, Cooke T, Bartlett JM. Aubele M, et al. Among authors: walch ak. Br J Cancer. 2008 Oct 7;99(7):1089-95. doi: 10.1038/sj.bjc.6604660. Epub 2008 Sep 9. Br J Cancer. 2008. PMID: 18781181 Free PMC article.

5

Classification of HER2/neu status in gastric cancer using a breast-cancer derived proteome classifier.

Balluff B, Elsner M, Kowarsch A, Rauser S, Meding S, Schuhmacher C, Feith M, Herrmann K, Röcken C, Schmid RM, Höfler H, Walch A, Ebert MP. Balluff B, et al. Among authors: walch a. J Proteome Res. 2010 Dec 3;9(12):6317-22. doi: 10.1021/pr100573s. Epub 2010 Nov 8. J Proteome Res. 2010. PMID: 21058730

6

Protein microarray-based comparison of HER2, estrogen receptor, and progesterone receptor status in core biopsies and surgical specimens from FFPE breast cancer tissues.

Berg D, Langer R, Tran K, Walch A, Schuster T, Bronger H, Becker KF. Berg D, et al. Among authors: walch a. Appl Immunohistochem Mol Morphol. 2011 Jul;19(4):300-5. doi: 10.1097/PAI.0b013e3182054f9f. Appl Immunohistochem Mol Morphol. 2011. PMID: 21293257

7

Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Luber B, Deplazes J, Keller G, Walch A, Rauser S, Eichmann M, Langer R, Höfler H, Hegewisch-Becker S, Folprecht G, Wöll E, Decker T, Endlicher E, Lorenzen S, Fend F, Peschel C, Lordick F. Luber B, et al. Among authors: walch a. BMC Cancer. 2011 Dec 7;11:509. doi: 10.1186/1471-2407-11-509. BMC Cancer. 2011. PMID: 22152101 Free PMC article. Clinical Trial.

8

The impact of cysteine-rich intestinal protein 1 (CRIP1) in human breast cancer.

Ludyga N, Englert S, Pflieger K, Rauser S, Braselmann H, Walch A, Auer G, Höfler H, Aubele M. Ludyga N, et al. Among authors: walch a. Mol Cancer. 2013 Apr 9;12:28. doi: 10.1186/1476-4598-12-28. Mol Cancer. 2013. PMID: 23570421 Free PMC article.

9

Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma.

Feuchtinger A, Stiehler T, Jütting U, Marjanovic G, Luber B, Langer R, Walch A. Feuchtinger A, et al. Among authors: walch a. Histochem Cell Biol. 2015 Jan;143(1):1-9. doi: 10.1007/s00418-014-1258-2. Epub 2014 Aug 26. Histochem Cell Biol. 2015. PMID: 25156293 Free article.

10

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.

Aichler M, Motschmann M, Jütting U, Luber B, Becker K, Ott K, Lordick F, Langer R, Feith M, Siewert JR, Walch A. Aichler M, et al. Among authors: walch a. Oncotarget. 2014 Aug 30;5(16):6620-32. doi: 10.18632/oncotarget.2268. Oncotarget. 2014. PMID: 25216514 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

422 results

Search Page

Filters